Search results
Jun 26, 2024 · Contact our media team. You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists. For any other request, please call the switchboard: +33 1 53 77 40 00. All the contacts.
We chase the miracles of science to improve people’s lives, and sometimes that means starting over with Plan B, Plan C, or even Plan Z. This film brings together the inner thoughts and ambitions of the people at Sanofi, who find inspiration from loved ones, motivation from families, and a united strength to push harder until we turn a corner.
Nov 30, 2022 · Press Release: Late-breaking Dupixent® (dupilumab) data at ERS 2022 show consistent efficacy and safety profile for up to two years in children aged 6 to 11 years with moderate-to-severe asthma. Read the Press Release. September 5, 2022.
Our Translational Science Hub in Brisbane connects Queensland’s world-class researchers with Sanofi scientists in France and the US, creating a first-of-its-kind, global scientific community focused on mRNA technology and translational science. It is proudly supported by Sanofi, Griffith University, The University of Queensland, and the ...
Waltham, MA Our mNRA Center of Excellence. We've grown our team to more than 500 Sanofians, all innovating every day. mRNA technology is a revolution in healthcare. Help bring treatments to more people, faster than before. Ridgefield, NJ Home to some of our best-in-class Specialty Care teams, Ridgefield is where thousands of Sanofians are doing ...
Om Sanofi Sverige. Vi är ett globalt läkemedelsföretag med över 90 000 medarbetare. Vi drivs av en gemensam vision - vi vill göra skillnad där det verkligen behövs. Vi tror att vår banbrytande forskning som drivs av data och digital teknik har potentialen att förvandla medicinutvecklingen och göra det omöjliga möjligt för ...
Third quarter 2023 results. Third quarter 2023 results were reviewed by management during a live audio webcast with the financial community on 27 October 2023. The presentation was followed by a Q&A session. 14:30 - 16:00 CET (8:30am – 10am EST) Quarterly Results. Discover more.
